10 insiders reported 120 Form 4 transactions for Bicara Therapeutics Inc. (BCAX) over the past 18 months (most recent 2026-05-20). Recent activity: Mazumdar Claire (Chief Executive Officer) Sell 12,022 shares, Mazumdar Claire (Chief Executive Officer) Buy 15,000 shares, Mazumdar Claire (Chief Executive Officer) Sell 2,978 shares, Cohlhepp Ryan (President and COO) Buy 8,000 shares, Cohlhepp Ryan (President and COO) Sell 8,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-20 | Mazumdar Claire | Chief Executive Officer | Sell | 12,022 | $239,982 |
| 2026-05-20 | Mazumdar Claire | Chief Executive Officer | Buy | 15,000 | $56,847 |
| 2026-05-20 | Mazumdar Claire | Chief Executive Officer | Sell | 2,978 | $60,597 |
| 2026-05-18 | Cohlhepp Ryan | President and COO | Buy | 8,000 | $30,318 |
| 2026-05-18 | Cohlhepp Ryan | President and COO | Sell | 8,000 | $162,335 |
| 2026-05-18 | Cohlhepp Ryan | President and COO | Sell | 4,500 | $91,314 |
| 2026-04-28 | Raben David | Chief Medical Officer | Buy | 5,500 | $20,844 |
| 2026-04-28 | Raben David | Chief Medical Officer | Sell | 5,500 | $125,830 |
| 2026-04-22 | Hyep Ivan | Chief Financial Officer | Buy | 9,200 | $34,866 |
| 2026-04-22 | Hyep Ivan | Chief Financial Officer | Sell | 9,200 | $211,614 |
| 2026-04-20 | Mazumdar Claire | Chief Executive Officer | Buy | 7,080 | $38,612 |
| 2026-04-20 | Mazumdar Claire | Chief Executive Officer | Buy | 7,454 | $28,249 |
| 2026-04-20 | Mazumdar Claire | Chief Executive Officer | Buy | 8,226 | $36,498 |
| 2026-04-20 | Mazumdar Claire | Chief Executive Officer | Buy | 15,000 | $56,847 |
| 2026-04-20 | Mazumdar Claire | Chief Executive Officer | Sell | 15,000 | $354,146 |
| 2026-04-17 | Cohlhepp Ryan | President and COO | Buy | 8,000 | $30,318 |
| 2026-04-17 | Cohlhepp Ryan | President and COO | Sell | 8,000 | $184,058 |
| 2026-04-17 | Cohlhepp Ryan | President and COO | Sell | 4,500 | $103,533 |
| 2026-03-26 | Raben David | Chief Medical Officer | Buy | 5,500 | $20,845 |
| 2026-03-26 | Raben David | Chief Medical Officer | Sell | 5,500 | $104,225 |
| 2026-03-24 | Hyep Ivan | Chief Financial Officer | Buy | 9,200 | $34,868 |
| 2026-03-24 | Hyep Ivan | Chief Financial Officer | Sell | 9,200 | $170,384 |
| 2026-03-20 | Mazumdar Claire | Chief Executive Officer | Buy | 6,499 | $24,631 |
| 2026-03-20 | Mazumdar Claire | Chief Executive Officer | Sell | 6,499 | $122,441 |
| 2026-03-20 | Mazumdar Claire | Chief Executive Officer | Buy | 6,905 | $26,170 |
Source: SEC Form 4 filings · as of 2026-05-20